| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = -$552,000 ) |
| | 2019 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | U01AI131861 | MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa | 001 | 2 | NIH | 4/18/2019 | -$342,000 |
| | 2019 | 2017 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | U01AI131861 | MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa | 003 | 1 | NIH | 9/5/2019 | -$210,000 |
|
| Issue Date FY: 2018 ( Subtotal = $354,000 ) |
| | 2018 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | R13AI136363 | 5th Global Forum on TB Vaccines | 000 | 1 | NIH | 1/25/2018 | $7,000 |
| | 2018 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | R13AI136363 | 5th Global Forum on TB Vaccines | 002 | 1 | NIH | 8/6/2018 | $0 |
| | 2018 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | R13AI136363 | 5th Global Forum on TB Vaccines | 000 | 1 | NIH | 1/25/2018 | $5,000 |
| | 2018 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | R13AI136363 | 5th Global Forum on TB Vaccines | 001 | 1 | NIH | 4/26/2018 | $0 |
| | 2018 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | R13AI136363 | 5th Global Forum on TB Vaccines | 001 | 1 | NIH | 4/26/2018 | $0 |
| | 2018 | 2018 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | U01AI131861 | MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa | 000 | 2 | NIH | 7/30/2018 | $342,000 |
|
| Issue Date FY: 2017 ( Subtotal = $210,000 ) |
| | 2017 | 2017 | AERAS | 1405 RESEARCH BLVD | ROCKVILLE | MD | 20850-3108 | MONTGOMERY | USA | U01AI131861 | MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa | 000 | 1 | NIH | 8/18/2017 | $210,000 |
|
| Issue Date FY: 2014 ( Subtotal = $0 ) |
| | 2014 | 2012 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI090691 | Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C | 000 | 3 | NIH | 2/20/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $0 ) |
| | 2013 | 2012 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 000 | 3 | FDA | 9/18/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $918,571 ) |
| | 2012 | 2012 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI090691 | Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C | 000 | 3 | NIH | 7/26/2012 | $619,046 |
| | 2012 | 2012 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 002 | 3 | FDA | 8/31/2012 | $299,525 |
| | 2012 | 2011 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 001 | 2 | FDA | 8/22/2012 | $0 |
| | 2012 | 2011 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 000 | 2 | FDA | 8/20/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $322,711 ) |
| | 2011 | 2011 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 004 | 2 | FDA | 9/19/2011 | $191,323 |
| | 2011 | 2011 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI090691 | Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C | 000 | 2 | NIH | 8/9/2011 | $131,388 |
| | 2011 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 002 | 1 | FDA | 4/5/2011 | $0 |
| | 2011 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 000 | 1 | FDA | 1/31/2011 | $0 |
| | 2011 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 001 | 1 | FDA | 3/18/2011 | $0 |
| | 2011 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 003 | 1 | FDA | 9/15/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $456,829 ) |
| | 2010 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI090691 | Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C | 000 | 1 | NIH | 7/25/2010 | $94,727 |
| | 2010 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI090691 | Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C | 001 | 1 | NIH | 7/30/2010 | $0 |
| | 2010 | 2010 | AERAS GLOBAL TB FOUNDATION | 1405 RESEARCH BLVD SUITE 300 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U18FD004012 | DISCOVERY OF BIOLOGICAL AND IMMUNOLOGICAL BIOMARKERS FOR TB VACCINES | 000 | 1 | FDA | 9/16/2010 | $362,102 |
|
| Issue Date FY: 2007 ( Subtotal = $217,000 ) |
| | 2007 | 2007 | AERAS GLOBAL TB FOUNDATION | 7500 old georgetown rd, #800 | BETHESDA | MD | 20814 | MONTGOMERY | USA | U10PS000060 | COMMUNITY-BASED SITES FOR EVALUATION OF NEW TB VACCINES | 001 | 3 | CDC | 9/19/2007 | $217,000 |
|
| Issue Date FY: 2006 ( Subtotal = $1,021,383 ) |
| | 2006 | 2006 | AERAS GLOBAL TB FOUNDATION | 7500 old georgetown rd, #800 | BETHESDA | MD | 20814 | MONTGOMERY | USA | R01AI055367 | OPTIMIZATION OF SALMONELLE-HIV-1 DNA VACCINE VECTORS | 000 | 5 | NIH | 2/15/2006 | $147,883 |
| | 2006 | 2006 | AERAS GLOBAL TB FOUNDATION | 7500 old georgetown rd, #800 | BETHESDA | MD | 20814 | MONTGOMERY | USA | U10PS000060 | COMMUNITY-BASED SITES FOR EVALUATION OF NEW TB VACCINES | 000 | 3 | CDC | 8/31/2006 | $873,500 |
|
| Issue Date FY: 2005 ( Subtotal = $1,305,100 ) |
| | 2005 | 2005 | AERAS GLOBAL TB FOUNDATION | | | | | | | R01AI055367 | OPTIMIZATION OF SALMONELLE-HIV-1 DNA VACCINE VECTORS | 000 | 4 | NIH | 8/10/2005 | $387,500 |
| | 2005 | 2005 | AERAS GLOBAL TB FOUNDATION | | | | | | | U10PS000060 | COMMUNITY-BASED SITES FOR EVALUATION OF NEW TB VACCINES | 000 | 2 | CDC | 9/6/2005 | $917,600 |
|
| Issue Date FY: 2004 ( Subtotal = $1,297,367 ) |
| | 2004 | 2004 | AERAS GLOBAL TB FOUNDATION | 9610 MEDICAL CENTER DR STE 220 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | U10PS000060 | COMMUNITY-BASED SITES FOR EVALUATION OF NEW TB VACCINES | 000 | 1 | CDC | 9/6/2004 | $924,867 |
| | 2004 | 2004 | AERAS GLOBAL TB FOUNDATION | 9610 MEDICAL CENTER DR STE 220 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI055367 | OPTIMIZATION OF SALMONELLE-HIV-1 DNA VACCINE VECTORS | 000 | 3 | NIH | 3/5/2004 | $372,500 |
|
| Issue Date FY: 2003 ( Subtotal = $426,415 ) |
| | 2003 | 2003 | AERAS GLOBAL TB FOUNDATION | 9610 MEDICAL CENTER DR STE 220 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI055367 | OPTIMIZATION OF SALMONELLE-HIV-1 DNA VACCINE VECTORS | 000 | 2 | NIH | 9/8/2003 | $253,650 |
| | 2003 | 2003 | AERAS GLOBAL TB FOUNDATION | 9610 MEDICAL CENTER DR STE 220 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI049497 | HIGH THROUGHPUT TB DRUG SCREENS | 000 | 3 | NIH | 7/1/2003 | $172,765 |
|
| Issue Date FY: 2002 ( Subtotal = $157,044 ) |
| | 2002 | 2002 | SEQUELLA GLOBAL TUBERCULOSIS FOUNDATION | 9610 MEDICAL CENTER DR STE 220 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI049497 | HIGH THROUGHPUT TB DRUG SCREENS | 000 | 2 | NIH | 8/30/2002 | $157,044 |
|
| Issue Date FY: 2001 ( Subtotal = $150,000 ) |
| | 2001 | 2001 | SEQUELLA GLOBAL TUBERCULOSIS FOUNDATION | 9610 MEDICAL CENTER DR STE 220 | ROCKVILLE | MD | 20850 | MONTGOMERY | USA | R01AI049497 | HIGH THROUGHPUT TB DRUG SCREENS | 000 | 1 | NIH | 9/17/2001 | $150,000 |
|
|
